Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells AK Nanayakkara, CA Follit, G Chen, NS Williams, PD Vogel, JG Wise Scientific reports 8 (1), 967, 2018 | 278 | 2018 |
ATP-binding properties of human Hsp90 T Scheibel, S Neuhofen, T Weikl, C Mayr, J Reinstein, PD Vogel, ... Journal of Biological Chemistry 272 (30), 18608-18613, 1997 | 142 | 1997 |
Role of extracellular and intracellular acidosis for hypercapnia-induced inhibition of tension of isolated rat cerebral arteries R Tian, P Vogel, NA Lassen, MJ Mulvany, F Andreasen, C Aalkjær Circulation research 76 (2), 269-275, 1995 | 108 | 1995 |
Multiple drug transport pathways through human P-glycoprotein JW McCormick, PD Vogel, JG Wise Biochemistry 54 (28), 4374-4390, 2015 | 94 | 2015 |
Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy S Delannoy, IL Urbatsch, G Tombline, AE Senior, PD Vogel Biochemistry 44 (42), 14010-14019, 2005 | 58 | 2005 |
In silico screening for inhibitors of p-glycoprotein that target the nucleotide binding domains FK Brewer, CA Follit, PD Vogel, JG Wise Molecular pharmacology 86 (6), 716-726, 2014 | 55 | 2014 |
Adenine nucleotide-binding sites on mitochondrial F1-ATPase. Evidence for an adenylate kinase-like orientation of catalytic and noncatalytic sites. PD Vogel, RL Cross Journal of Biological Chemistry 266 (10), 6101-6105, 1991 | 50 | 1991 |
Effects of psychosocial stress on the pattern of salivary protein release AF Trueba, D Mizrachi, RJ Auchus, PD Vogel, T Ritz Physiology & behavior 105 (3), 841-849, 2012 | 49 | 2012 |
Photoaffinity labeling of wild-type and mutant forms of the yeast V-ATPase A subunit by 2-azido-[32P] ADP KJ MacLeod, E Vasilyeva, K Merdek, PD Vogel, M Forgac Journal of Biological Chemistry 274 (46), 32869-32874, 1999 | 43 | 1999 |
Nature's design of nanomotors PD Vogel European journal of pharmaceutics and biopharmaceutics 60 (2), 267-277, 2005 | 40 | 2005 |
Nucleotide binding sites on mitochondrial F1-ATPase. Electron spin resonance spectroscopy and photolabeling by azido-spin-labeled adenine nucleotides support an adenylate … PD Vogel, JH Nett, HE Sauer, K Schmadel, RL Cross, WE Trommer Journal of Biological Chemistry 267 (17), 11982-11986, 1992 | 36 | 1992 |
Synthesis of a photoaffinity-spin-labeled derivative of ATP and its first application to F1-ATPase P Vogel-Claude, G Schäfer, WE Trommer FEBS letters 227 (2), 107-109, 1988 | 36 | 1988 |
A thermodynamic coupling mechanism for the disaggregation of a model peptide substrate by chaperone SecB VG Panse, P Vogel, WE Trommer, R Varadarajan Journal of Biological Chemistry 275 (25), 18698-18703, 2000 | 34 | 2000 |
Effects of magnesium ions on the relative conformation of nucleotide binding sites of F1-ATPases as studied by electron spin resonance spectroscopy. S Burgard, JH Nett, HE Sauer, Y Kagawa, HJ Schäfer, JG Wise, PD Vogel, ... Journal of Biological Chemistry 269 (27), 17815-17819, 1994 | 34 | 1994 |
In silico identified targeted inhibitors of P‐glycoprotein overcome multidrug resistance in human cancer cells in culture CA Follit, FK Brewer, JG Wise, PD Vogel Pharmacology research & perspectives 3 (5), e00170, 2015 | 30 | 2015 |
The subunit b dimer of the FoF1-ATP synthase: interaction with F1-ATPase as deduced by site-specific spin-labeling C Motz, T Hornung, M Kersten, DT McLachlin, SD Dunn, JG Wise, ... Journal of Biological Chemistry 279 (47), 49074-49081, 2004 | 29 | 2004 |
Site-directed spin-labeling of the catalytic sites yields insight into structural changes within the FoF1-ATP synthase of Escherichia coli MV Kersten, SD Dunn, JG Wise, PD Vogel Biochemistry 39 (13), 3856-3860, 2000 | 28 | 2000 |
Insights into the regulation of the ryanodine receptor: differential effects of Mg2+ and Ca2+ on ATP binding JM Dias, C Szegedi, I Jóna, PD Vogel Biochemistry 45 (31), 9408-9415, 2006 | 27 | 2006 |
Transport of Alzheimer’s associated amyloid-β catalyzed by P-glycoprotein JW McCormick, L Ammerman, G Chen, PD Vogel, JG Wise PLoS One 16 (4), e0250371, 2021 | 25 | 2021 |
Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravis M Hossann, Z Li, Y Shi, U Kreilinger, J Büttner, PD Vogel, J Yuan, ... Protein expression and purification 46 (1), 73-84, 2006 | 25 | 2006 |